詳細検索

詳細検索

お問い合わせ

2026年~2032年の世界更年期用サプリメント市場の成長見通し

2026年~2032年の世界更年期用サプリメント市場の成長見通し


Global Supplement for Menopause Market Growth 2026-2032

世界の更年期用サプリメント市場規模は、2025年の17億9400万米ドルから2032年には32億9600万米ドルへと拡大すると予測されており、2026年から2032年にかけて年平均成長率(CAGR)9.3%で成長すると見込まれていま... もっと見る

 

 

出版社
LP Information
LPインフォメーション
出版年月
2026年9月15日
電子版価格
US$3,660
シングルユーザーライセンス
ライセンス・価格情報/注文方法はこちら
納期
3-5営業日程度
ページ数
158
言語
英語

英語原文をAIを使って翻訳しています。


 

サマリー

世界の更年期用サプリメント市場規模は、2025年の17億9400万米ドルから2032年には32億9600万米ドルへと拡大すると予測されており、2026年から2032年にかけて年平均成長率(CAGR)9.3%で成長すると見込まれています。
更年期用サプリメントは、更年期における女性の卵巣機能障害やエストロゲンレベルの変動・低下によって引き起こされる身体的・心理的な不快症状を緩和するために設計された栄養補助食品です。 通常、天然植物エキス(大豆イソフラボン、ブラックコホシュ、ザクロフラボノイドなど)、ビタミン(ビタミンDやビタミンB群など)、ミネラル(カルシウム、マグネシウム、亜鉛など)、プロバイオティクス(腸-エストロゲン軸を調節する特定の菌株など)、 オメガ3脂肪酸を主要成分として配合しています。科学的に算出された配合比率により、体内のホルモンバランスを模倣・サポートし、骨の健康を強化し、神経伝達機能を改善し、気分や抗酸化防御システムを調節することで、更年期の女性がホルモンが激しく変動する生理的移行期を円滑に乗り越え、骨粗鬆症、心血管疾患、認知機能の低下などを軽減することを目的としています。
更年期サプリメントの世界市場は、数多くの発展機会と顕著なトレンドを迎えています。世界的な人口の高齢化が加速する中、2030年までに世界中で12億人以上の女性が更年期を迎え、中国だけでも2億人以上の更年期女性が存在すると推定されています。 この巨大な消費者層は、市場の成長に向けた強固な基盤を築いています。同時に、女性の健康意識は著しく向上しており、更年期女性の80%以上が不快な症状を経験しています。ほてり、不眠、骨粗鬆症などの問題を緩和したいという需要が、市場の拡大を牽引しています。 トレンドの観点から見ると、天然成分の革新が中核的な方向性となっている。フィトエストロゲン(大豆イソフラボン、ザクロフラボノイドなど)、コラーゲンペプチド、オメガ3脂肪酸といった成分が注目されている。臨床試験により、これらが骨密度、肌の弾力性、心血管の健康を改善できることが確認されている。 パーソナライゼーションとテクノロジーの融合が加速している。AIを活用した栄養管理システムは、血液検査値や食事記録などのデータを統合し、日々の栄養摂取に関する推奨事項を提供する。ウェアラブルデバイスは心拍変動や睡眠の質をモニタリングし、更年期症状の管理を支援する。さらに、市場は細分化され、競争においても差別化が進んでいる。 一線都市の女性はハイエンドな医療サービスやデジタルツールを好む一方、二線以下の都市では医師の推奨やコストパフォーマンスに優れた製品が頼りにされています。企業は、各都市レベルに応じて販路やマーケティング戦略を最適化する必要があります。全体として、更年期用サプリメント市場は、需要、政策指針、技術革新に牽引され、今後も拡大を続けるでしょう。
LP Information, Inc. (LPI) の最新調査レポート『更年期用サプリメント業界予測』は、過去の売上実績を検証し、2025年の世界全体の更年期用サプリメント売上高を分析するとともに、2026年から2032年までの更年期用サプリメント売上高予測について、地域および市場セクター別の包括的な分析を提供しています。 本レポートでは、更年期用サプリメントの売上高を地域、市場セクター、サブセクターごとに分類し、世界の更年期用サプリメント業界について、単位:百万米ドルで詳細な分析を行っています。
本インサイトレポートは、世界更年期サプリメント市場の全体像を包括的に分析し、製品セグメンテーション、企業構成、収益、市場シェア、最新動向、およびM&A活動に関連する主要なトレンドを明らかにしています。 また、本レポートでは、更年期用サプリメントのポートフォリオと能力、市場参入戦略、市場での位置づけ、および地理的展開に焦点を当て、世界的な更年期用サプリメント市場の成長が加速する中で、主要グローバル企業の戦略を分析し、これらの企業が持つ独自の立場をより深く理解できるようにしています。
本インサイトレポートでは、更年期向けサプリメントの世界的な見通しを形作る主要な市場動向、推進要因、および影響要因を評価し、タイプ別、用途別、地域別、市場規模別に予測を細分化することで、新興のビジネスチャンスを浮き彫りにしています。 数百件に及ぶボトムアップ型の定性的・定量的市場データに基づく透明性の高い方法論により、本調査の予測は、世界的な更年期向けサプリメント市場の現状と将来の動向について、極めて精緻な見解を提供します。
本レポートでは、製品タイプ、用途、主要メーカー、および主要地域・国別に、更年期向けサプリメント市場の包括的な概要、市場シェア、成長機会を提示しています。
タイプ別セグメンテーション:
ホルモン調節サプリメント
骨の健康サプリメント
心血管・代謝サポートサプリメント
気分・睡眠調節サプリメント
その他
用途別セグメンテーション:
オンライン薬局
小売薬局
病院
また、本レポートでは地域別に市場を分類しています:
南北アメリカ
米国
カナダ
メキシコ
ブラジル
アジア太平洋地域(APAC)
中国
日本
韓国
東南アジア
インド
オーストラリア
ヨーロッパ
ドイツ
フランス
英国
イタリア
ロシア
中東・アフリカ
エジプト
南アフリカ
イスラエル
トルコ
GCC諸国
以下に紹介する企業は、主要な専門家からの情報および各社の事業範囲、製品ポートフォリオ、市場浸透度を分析した上で選定されています。
AdvaCare Pharma
Amerifit Brands (Estroven)
Biofarma Group
Bonafide Health
Equelle
Flourish
GNC
小林製薬
Makers Nutrition
Menoelle
MenoLabs
Menopace
New Nordic
Nordic Naturals
大塚製薬
PharmaLinea
フィトライフ・ファーマ
プロメンシル
SMPニュートラ
ザ・ベター・メノポーズ
ビタバイオティクス
本レポートで取り上げる主な質問
世界の更年期用サプリメント市場の今後10年間の見通しは?
世界全体および地域別に、更年期用サプリメント市場の成長を牽引している要因は何か?
市場および地域別に、最も急速な成長が見込まれる技術はどれか?
更年期用サプリメント市場のビジネスチャンスは、エンド市場の規模によってどのように異なるか?
更年期用サプリメントは、種類別、用途別にどのように分類されるか?


お問い合わせ

お問合せ種類/内容 *

補足が有ればご記入ください
貴社名*
ご担当者名 * 姓 名
メールアドレス *

ページTOPに戻る


目次

1 本レポートの範囲
1.1 市場の概要
1.2 対象期間
1.3 調査目的
1.4 市場調査の方法論
1.5 調査プロセスおよびデータソース
1.6 経済指標
1.7 対象通貨
1.8 市場推計に関する留意事項

2 エグゼクティブ・サマリー
2.1 世界市場の概要
2.1.1 更年期サプリメントの世界年間売上高(2021年~2032年)
2.1.2 地域別更年期用サプリメントの世界の現状および将来分析(2021年、2025年、2032年)
2.1.3 国・地域別 更年期用サプリメントの世界の現状および将来分析(2021年、2025年、2032年)
2.2 種類別 更年期用サプリメントのセグメント
2.2.1 ホルモン調節サプリメント
2.2.2 骨の健康をサポートするサプリメント
2.2.3 心血管および代謝をサポートするサプリメント
2.2.4 気分および睡眠の調節をサポートするサプリメント
2.2.5 その他
2.2.6 更年期用サプリメントのタイプ別売上高
2.2.6.1 更年期向けサプリメントの世界市場における種類別売上高シェア(2021年~2026年)
2.2.6.2 更年期向けサプリメントの世界市場における種類別売上高および市場シェア(2021年~2026年)
2.2.6.3 世界更年期用サプリメントの販売価格(種類別)(2021-2026年)
2.3 用途別更年期用サプリメントセグメント
2.3.1 オンライン薬局
2.3.2 小売薬局
2.3.3 病院
2.3.4 用途別更年期用サプリメント売上高
2.3.4.1 用途別世界更年期用サプリメント販売市場シェア(2021年~2026年)
2.3.4.2 用途別世界更年期用サプリメント売上高および市場シェア(2021年~2026年)
2.3.4.3 用途別 世界更年期用サプリメント販売価格(2021-2026年)

3 企業別(世界)
3.1 企業別 世界更年期用サプリメント内訳データ
3.1.1 企業別 世界更年期用サプリメント年間売上高 (2021年~2026年)
3.1.2 世界更年期用サプリメント市場における企業別販売シェア(2021年~2026年)
3.2 世界更年期用サプリメントの企業別年間売上高(2021年~2026年)
3.2.1 更年期用サプリメントの世界市場:企業別収益(2021-2026年)
3.2.2 更年期用サプリメントの世界市場:企業別収益市場シェア(2021-2026年)
3.3 更年期用サプリメントの世界市場:企業別販売価格
3.4 主要メーカーの更年期用サプリメントの生産地域別分布、販売地域、製品タイプ
3.4.1 主要メーカーの更年期用サプリメントの生産拠点分布
3.4.2 主要メーカーが提供する更年期用サプリメント製品
3.5 市場集中率分析
3.5.1 競争環境分析
3.5.2 集中率(CR3、CR5、CR10)(2024年~2026年)
3.6 新製品および新規参入候補企業
3.7 市場のM&A動向および戦略

4 地域別 更年期用サプリメントの世界市場推移
4.1 地域別 更年期用サプリメントの世界市場規模(2021-2026年)
4.1.1 地域別 更年期用サプリメントの世界年間売上高(2021-2026年)
4.1.2 地域別 世界更年期サプリメントの年間収益(2021年~2026年)
4.2 国・地域別 世界更年期サプリメント市場の過去実績規模(2021年~2026年)
4.2.1 国・地域別 世界更年期用サプリメントの年間販売数量(2021-2026年)
4.2.2 国・地域別 世界更年期用サプリメントの年間売上高(2021-2026年)
4.3 アメリカ大陸における更年期用サプリメントの販売成長
4.4 アジア太平洋地域(APAC)における更年期用サプリメントの販売成長
4.5 ヨーロッパにおける更年期用サプリメントの販売成長
4.6 中東・アフリカにおける更年期用サプリメントの販売成長

5 米州
5.1 米州における更年期用サプリメントの国別売上高
5.1.1 米州における更年期用サプリメントの国別売上高(2021年~2026年)
5.1.2 米州における更年期用サプリメントの国別売上高(2021年~2026年)
5.2 米州における更年期向けサプリメントの販売状況(種類別)(2021-2026年)
5.3 米州における更年期向けサプリメントの販売状況(用途別)(2021-2026年)
5.4 米国
5.5 カナダ
5.6 メキシコ
5.7 ブラジル

6 アジア太平洋地域(APAC)
6.1 アジア太平洋地域(APAC)における更年期用サプリメントの販売状況(地域別)
6.1.1 アジア太平洋地域(APAC)における更年期用サプリメントの販売状況(地域別)(2021年~2026年)
6.1.2 アジア太平洋地域(APAC)における更年期用サプリメントの売上高(地域別)(2021年~2026年)
6.2 アジア太平洋地域(APAC)の更年期用サプリメント販売数(種類別)(2021年~2026年)
6.3 アジア太平洋地域(APAC)の更年期用サプリメント販売数(用途別)(2021年~2026年)
6.4 中国
6.5 日本
6.6 韓国
6.7 東南アジア
6.8 インド
6.9 オーストラリア
6.10 台湾

7 欧州
7.1 欧州:更年期関連の国別補足データ
7.1.1 欧州:更年期関連の国別売上高(2021-2026)
7.1.2 欧州の更年期用サプリメントの国別収益(2021年~2026年)
7.2 欧州の更年期用サプリメントの販売状況(種類別)(2021年~2026年)
7.3 欧州の更年期用サプリメント:用途別販売数(2021年~2026年)
7.4 ドイツ
7.5 フランス
7.6 英国
7.7 イタリア
7.8 ロシア

8 中東・アフリカ
8.1 中東・アフリカ:更年期関連サプリメントの国別概要
8.1.1 中東・アフリカ:更年期関連サプリメントの販売額(国別)(2021-2026年)
8.1.2 中東・アフリカ:更年期関連サプリメントの売上高(国別)(2021-2026年)
8.2 中東・アフリカにおける更年期用サプリメントの販売数量(種類別)(2021年~2026年)
8.3 中東・アフリカにおける更年期用サプリメントの販売数量(用途別)(2021年~2026年)
8.4 エジプト
8.5 南アフリカ
8.6 イスラエル
8.7 トルコ
8.8 GCC諸国

9 市場の推進要因、課題および動向
9.1 市場の推進要因および成長機会
9.2 市場の課題およびリスク
9.3 業界の動向

10 製造コスト構造の分析
10.1 原材料およびサプライヤー
10.2 更年期用サプリメントの製造コスト構造の分析
10.3 更年期用サプリメントの製造プロセスの分析
10.4 更年期用サプリメントの産業チェーン構造

11 マーケティング、販売業者および顧客
11.1 販売チャネル
11.1.1 直接チャネル
11.1.2 間接チャネル
11.2 更年期用サプリメントの販売業者
11.3 更年期用サプリメントの顧客

12 地域別更年期サプリメントの世界市場予測の概要
12.1 地域別世界更年期サプリメント市場規模予測
12.1.1 地域別世界更年期サプリメント市場予測(2027年~2032年)
12.1.2 地域別 更年期向けサプリメントの世界年間売上高予測(2027年~2032年)
12.2 国別 米州市場予測(2027年~2032年)
12.3 アジア太平洋地域(APAC)の地域別予測(2027年~2032年)
12.4 ヨーロッパの国別予測(2027年~2032年)
12.5 中東・アフリカの国別予測(2027年~2032年)
12.6 更年期向けサプリメントの世界市場予測(タイプ別)(2027年~2032年)
12.7 更年期向けサプリメントの世界市場予測(用途別)(2027年~2032年)

13 主要企業分析
13.1 AdvaCare Pharma
13.1.1 AdvaCare Pharma 企業情報
13.1.2 AdvaCare Pharma 更年期用サプリメントの製品ポートフォリオおよび仕様
13.1.3 AdvaCare Pharma 更年期用サプリメントの販売数量、売上高、価格、粗利益率(2021-2026年)
13.1.4 アドバケア・ファーマの主要事業概要
13.1.5 アドバケア・ファーマの最新動向
13.2 アメリフィット・ブランズ(エストロヴェン)
13.2.1 アメリフィット・ブランズ(エストロヴェン)の企業情報
13.2.2 Amerifit Brands(エストロヴェン)更年期向けサプリメントの製品ポートフォリオおよび仕様
13.2.3 Amerifit Brands(エストロヴェン)更年期向けサプリメントの販売数量、売上高、価格および粗利益率(2021年~2026年)
13.2.4 アメリフィット・ブランズ(エストロヴェン)の主な事業概要
13.2.5 アメリフィット・ブランズ(エストロヴェン)の最新動向
13.3 バイオファーマ・グループ
13.3.1 バイオファーマ・グループの企業情報
13.3.2 バイオファーマ・グループの更年期向けサプリメントの製品ポートフォリオおよび仕様
13.3.3 バイオファーマ・グループの更年期向けサプリメントの販売数量、売上高、価格、粗利益率(2021年~2026年)
13.3.4 バイオファーマ・グループの主要事業概要
13.3.5 バイオファーマ・グループの最新動向
13.4 ボナファイド・ヘルス
13.4.1 ボナファイド・ヘルスの企業情報
13.4.2 ボナファイド・ヘルスの更年期向けサプリメントの製品ポートフォリオおよび仕様
13.4.3 ボナファイド・ヘルスの更年期向けサプリメントの販売数、売上高、価格、粗利益率(2021年~2026年)
13.4.4 ボナファイド・ヘルスの主要事業概要
13.4.5 ボナファイド・ヘルスの最新動向
13.5 エクエル
13.5.1 エクエルの企業情報
13.5.2 エクエルの更年期向けサプリメントの製品ポートフォリオおよび仕様
13.5.3 エクエル(Equelle)の更年期向けサプリメントの販売数量、売上高、価格、粗利益率(2021年~2026年)
13.5.4 エクエル(Equelle)の主要事業概要
13.5.5 エクエル(Equelle)の最新動向
13.6 フラリッシュ(Flourish)
13.6.1 フラリッシュの企業情報
13.6.2 フラリッシュの更年期向けサプリメントの製品ポートフォリオおよび仕様
13.6.3 フラリッシュの更年期向けサプリメントの販売数、売上高、価格、粗利益率(2021年~2026年)
13.6.4 フラリッシュの主な事業概要
13.6.5 フラリッシュの最新動向
13.7 GNC
13.7.1 GNCの企業情報
13.7.2 GNCの更年期向けサプリメントの製品ポートフォリオおよび仕様
13.7.3 GNCの更年期向けサプリメントの販売数量、売上高、価格、粗利益率(2021年~2026年)
13.7.4 GNCの主要事業概要
13.7.5 GNCの最新動向
13.8 小林製薬
13.8.1 小林製薬の企業情報
13.8.2 小林製薬の更年期向けサプリメントの製品ポートフォリオおよび仕様
13.8.3 小林製薬の更年期向けサプリメントの販売数、売上高、価格、粗利益率(2021年~2026年)
13.8.4 小林製薬の主な事業概要
13.8.5 小林製薬の最新動向
13.9 メイカーズ・ニュートリション
13.9.1 メイカーズ・ニュートリションの企業情報
13.9.2 メイカーズ・ニュートリションの更年期向けサプリメントの製品ポートフォリオおよび仕様
13.9.3 メイカーズ・ニュートリションの更年期向けサプリメントの販売数、売上高、価格、粗利益率(2021年~2026年)
13.9.4 メイカーズ・ニュートリションの主要事業概要
13.9.5 メイカーズ・ニュートリションの最新動向
13.10 メノエル
13.10.1 メノエルの企業情報
13.10.2 メノエルの更年期向けサプリメントの製品ポートフォリオおよび仕様
13.10.3 メノエルの更年期向けサプリメントの販売数、売上高、価格、粗利益率(2021年~2026年)
13.10.4 メノエルの主な事業概要
13.10.5 メノエルの最新動向
13.11 メノラボ
13.11.1 メノラボスの企業情報
13.11.2 メノラボスの更年期向けサプリメントの製品ポートフォリオおよび仕様
13.11.3 メノラボスの更年期向けサプリメントの販売数、売上高、価格、粗利益率(2021年~2026年)
13.11.4 MenoLabsの主要事業概要
13.11.5 MenoLabsの最新動向
13.12 Menopace
13.12.1 Menopaceの企業情報
13.12.2 メノペースの更年期向けサプリメント製品ポートフォリオおよび仕様
13.12.3 メノペースの更年期向けサプリメントの販売数、売上高、価格、粗利益率(2021年~2026年)
13.12.4 メノペースの主要事業概要
13.12.5 メノペースの最新動向
13.13 ニュー・ノルディック
13.13.1 ニュー・ノルディックの企業情報
13.13.2 ニュー・ノルディックの更年期向けサプリメントの製品ポートフォリオおよび仕様
13.13.3 ニュー・ノルディックの更年期向けサプリメントの販売数量、売上高、価格および粗利益率(2021年~2026年)
13.13.4 ニュー・ノルディックの主な事業概要
13.13.5 ニュー・ノルディックの最新動向
13.14 ノルディック・ナチュラルズ
13.14.1 ノルディック・ナチュラルズの企業情報
13.14.2 ノルディック・ナチュラルズの更年期向けサプリメントの製品ポートフォリオおよび仕様
13.14.3 ノルディック・ナチュラルズの更年期向けサプリメントの販売数、売上高、価格、粗利益率(2021年~2026年)
13.14.4 ノルディック・ナチュラルズの主要事業概要
13.14.5 ノルディック・ナチュラルズの最新動向
13.15 大塚製薬
13.15.1 大塚製薬の企業情報
13.15.2 大塚製薬の更年期向けサプリメントの製品ポートフォリオおよび仕様
13.15.3 大塚製薬の更年期向けサプリメントの販売数量、売上高、価格、粗利益率(2021年~2026年)
13.15.4 大塚製薬の主要事業概要
13.15.5 大塚製薬の最新動向
13.16 ファーマリネア
13.16.1 ファーマリネアの企業情報
13.16.2 ファーマリネアの更年期用サプリメントの製品ポートフォリオおよび仕様
13.16.3 ファーマリネア 更年期用サプリメントの販売数量、売上高、価格、粗利益率(2021年~2026年)
13.16.4 ファーマリネアの主要事業概要
13.16.5 ファーマリネアの最新動向
13.17 フィトライフ・ファーマ
13.17.1 フィトライフ・ファーマの企業情報
13.17.2 フィトライフ・ファーマの更年期向けサプリメントの製品ポートフォリオおよび仕様
13.17.3 フィトライフ・ファーマの更年期向けサプリメントの販売数、売上高、価格、粗利益率 (2021年~2026年)
13.17.4 フィトライフ・ファーマの主な事業概要
13.17.5 フィトライフ・ファーマの最新動向
13.18 プロメンシル
13.18.1 プロメンシルの企業情報
13.18.2 プロメンシル更年期用サプリメントの製品ポートフォリオおよび仕様
13.18.3 プロメンシル更年期用サプリメントの販売数量、売上高、価格および粗利益率 (2021-2026)
13.18.4 プロメンシルの主要事業概要
13.18.5 プロメンシルの最新動向
13.19 SMPNutra
13.19.1 SMPNutraの企業情報
13.19.2 SMPNutraの更年期向けサプリメントの製品ポートフォリオおよび仕様
13.19.3 SMPNutraの更年期向けサプリメントの販売数、売上高、価格、粗利益率(2021年~2026年)
13.19.4 SMPNutraの主要事業概要
13.19.5 SMPNutraの最新動向
13.20 The Better Menopause
13.20.1 The Better Menopauseの企業情報
13.20.2 The Better Menopauseの更年期向けサプリメント製品ポートフォリオおよび仕様
13.20.3 The Better Menopauseの更年期向けサプリメントの販売数、売上高、価格、粗利益率(2021年~2026年)
13.20.4 The Better Menopauseの主要事業概要
13.20.5 The Better Menopauseの最新動向
13.21 Vitabiotics
13.21.1 ヴィタバイオティクスの企業情報
13.21.2 ヴィタバイオティクスの更年期向けサプリメントの製品ポートフォリオおよび仕様
13.21.3 ヴィタバイオティクスの更年期向けサプリメントの販売数、売上高、価格、粗利益率(2021年~2026年)
13.21.4 ヴィタバイオティクスの主要事業概要
13.21.5 ヴィタバイオティクスの最新動向

14 調査結果と結論

ページTOPに戻る



図表リスト

List of Tables
Table 1. Supplement for Menopause Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Supplement for Menopause Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Hormone Regulation Supplements
Table 4. Major Players of Bone Health Supplements
Table 5. Major Players of Cardiovascular and Metabolic Support Supplements
Table 6. Major Players of Mood and Sleep Regulation Supplements
Table 7. Major Players of Others
Table 8. Global Supplement for Menopause Sales by Type (2021-2026) & (K Units)
Table 9. Global Supplement for Menopause Sales Market Share by Type (2021-2026)
Table 10. Global Supplement for Menopause Revenue by Type (2021-2026) & ($ million)
Table 11. Global Supplement for Menopause Revenue Market Share by Type (2021-2026)
Table 12. Global Supplement for Menopause Sale Price by Type (2021-2026) & (US$/Unit)
Table 13. Global Supplement for Menopause Sale by Application (2021-2026) & (K Units)
Table 14. Global Supplement for Menopause Sale Market Share by Application (2021-2026)
Table 15. Global Supplement for Menopause Revenue by Application (2021-2026) & ($ million)
Table 16. Global Supplement for Menopause Revenue Market Share by Application (2021-2026)
Table 17. Global Supplement for Menopause Sale Price by Application (2021-2026) & (US$/Unit)
Table 18. Global Supplement for Menopause Sales by Company (2021-2026) & (K Units)
Table 19. Global Supplement for Menopause Sales Market Share by Company (2021-2026)
Table 20. Global Supplement for Menopause Revenue by Company (2021-2026) & ($ millions)
Table 21. Global Supplement for Menopause Revenue Market Share by Company (2021-2026)
Table 22. Global Supplement for Menopause Sale Price by Company (2021-2026) & (US$/Unit)
Table 23. Key Manufacturers Supplement for Menopause Producing Area Distribution and Sales Area
Table 24. Players Supplement for Menopause Products Offered
Table 25. Supplement for Menopause Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 26. New Products and Potential Entrants
Table 27. Market M&A Activity & Strategy
Table 28. Global Supplement for Menopause Sales by Geographic Region (2021-2026) & (K Units)
Table 29. Global Supplement for Menopause Sales Market Share Geographic Region (2021-2026)
Table 30. Global Supplement for Menopause Revenue by Geographic Region (2021-2026) & ($ millions)
Table 31. Global Supplement for Menopause Revenue Market Share by Geographic Region (2021-2026)
Table 32. Global Supplement for Menopause Sales by Country/Region (2021-2026) & (K Units)
Table 33. Global Supplement for Menopause Sales Market Share by Country/Region (2021-2026)
Table 34. Global Supplement for Menopause Revenue by Country/Region (2021-2026) & ($ millions)
Table 35. Global Supplement for Menopause Revenue Market Share by Country/Region (2021-2026)
Table 36. Americas Supplement for Menopause Sales by Country (2021-2026) & (K Units)
Table 37. Americas Supplement for Menopause Sales Market Share by Country (2021-2026)
Table 38. Americas Supplement for Menopause Revenue by Country (2021-2026) & ($ millions)
Table 39. Americas Supplement for Menopause Sales by Type (2021-2026) & (K Units)
Table 40. Americas Supplement for Menopause Sales by Application (2021-2026) & (K Units)
Table 41. APAC Supplement for Menopause Sales by Region (2021-2026) & (K Units)
Table 42. APAC Supplement for Menopause Sales Market Share by Region (2021-2026)
Table 43. APAC Supplement for Menopause Revenue by Region (2021-2026) & ($ millions)
Table 44. APAC Supplement for Menopause Sales by Type (2021-2026) & (K Units)
Table 45. APAC Supplement for Menopause Sales by Application (2021-2026) & (K Units)
Table 46. Europe Supplement for Menopause Sales by Country (2021-2026) & (K Units)
Table 47. Europe Supplement for Menopause Revenue by Country (2021-2026) & ($ millions)
Table 48. Europe Supplement for Menopause Sales by Type (2021-2026) & (K Units)
Table 49. Europe Supplement for Menopause Sales by Application (2021-2026) & (K Units)
Table 50. Middle East & Africa Supplement for Menopause Sales by Country (2021-2026) & (K Units)
Table 51. Middle East & Africa Supplement for Menopause Revenue Market Share by Country (2021-2026)
Table 52. Middle East & Africa Supplement for Menopause Sales by Type (2021-2026) & (K Units)
Table 53. Middle East & Africa Supplement for Menopause Sales by Application (2021-2026) & (K Units)
Table 54. Key Market Drivers & Growth Opportunities of Supplement for Menopause
Table 55. Key Market Challenges & Risks of Supplement for Menopause
Table 56. Key Industry Trends of Supplement for Menopause
Table 57. Supplement for Menopause Raw Material
Table 58. Key Suppliers of Raw Materials
Table 59. Supplement for Menopause Distributors List
Table 60. Supplement for Menopause Customer List
Table 61. Global Supplement for Menopause Sales Forecast by Region (2027-2032) & (K Units)
Table 62. Global Supplement for Menopause Revenue Forecast by Region (2027-2032) & ($ millions)
Table 63. Americas Supplement for Menopause Sales Forecast by Country (2027-2032) & (K Units)
Table 64. Americas Supplement for Menopause Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 65. APAC Supplement for Menopause Sales Forecast by Region (2027-2032) & (K Units)
Table 66. APAC Supplement for Menopause Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 67. Europe Supplement for Menopause Sales Forecast by Country (2027-2032) & (K Units)
Table 68. Europe Supplement for Menopause Revenue Forecast by Country (2027-2032) & ($ millions)
Table 69. Middle East & Africa Supplement for Menopause Sales Forecast by Country (2027-2032) & (K Units)
Table 70. Middle East & Africa Supplement for Menopause Revenue Forecast by Country (2027-2032) & ($ millions)
Table 71. Global Supplement for Menopause Sales Forecast by Type (2027-2032) & (K Units)
Table 72. Global Supplement for Menopause Revenue Forecast by Type (2027-2032) & ($ millions)
Table 73. Global Supplement for Menopause Sales Forecast by Application (2027-2032) & (K Units)
Table 74. Global Supplement for Menopause Revenue Forecast by Application (2027-2032) & ($ millions)
Table 75. AdvaCare Pharma Basic Information, Supplement for Menopause Manufacturing Base, Sales Area and Its Competitors
Table 76. AdvaCare Pharma Supplement for Menopause Product Portfolios and Specifications
Table 77. AdvaCare Pharma Supplement for Menopause Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 78. AdvaCare Pharma Main Business
Table 79. AdvaCare Pharma Latest Developments
Table 80. Amerifit Brands (Estroven) Basic Information, Supplement for Menopause Manufacturing Base, Sales Area and Its Competitors
Table 81. Amerifit Brands (Estroven) Supplement for Menopause Product Portfolios and Specifications
Table 82. Amerifit Brands (Estroven) Supplement for Menopause Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 83. Amerifit Brands (Estroven) Main Business
Table 84. Amerifit Brands (Estroven) Latest Developments
Table 85. Biofarma Group Basic Information, Supplement for Menopause Manufacturing Base, Sales Area and Its Competitors
Table 86. Biofarma Group Supplement for Menopause Product Portfolios and Specifications
Table 87. Biofarma Group Supplement for Menopause Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 88. Biofarma Group Main Business
Table 89. Biofarma Group Latest Developments
Table 90. Bonafide Health Basic Information, Supplement for Menopause Manufacturing Base, Sales Area and Its Competitors
Table 91. Bonafide Health Supplement for Menopause Product Portfolios and Specifications
Table 92. Bonafide Health Supplement for Menopause Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 93. Bonafide Health Main Business
Table 94. Bonafide Health Latest Developments
Table 95. Equelle Basic Information, Supplement for Menopause Manufacturing Base, Sales Area and Its Competitors
Table 96. Equelle Supplement for Menopause Product Portfolios and Specifications
Table 97. Equelle Supplement for Menopause Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 98. Equelle Main Business
Table 99. Equelle Latest Developments
Table 100. Flourish Basic Information, Supplement for Menopause Manufacturing Base, Sales Area and Its Competitors
Table 101. Flourish Supplement for Menopause Product Portfolios and Specifications
Table 102. Flourish Supplement for Menopause Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 103. Flourish Main Business
Table 104. Flourish Latest Developments
Table 105. GNC Basic Information, Supplement for Menopause Manufacturing Base, Sales Area and Its Competitors
Table 106. GNC Supplement for Menopause Product Portfolios and Specifications
Table 107. GNC Supplement for Menopause Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 108. GNC Main Business
Table 109. GNC Latest Developments
Table 110. Kobayashi Pharmaceutical Basic Information, Supplement for Menopause Manufacturing Base, Sales Area and Its Competitors
Table 111. Kobayashi Pharmaceutical Supplement for Menopause Product Portfolios and Specifications
Table 112. Kobayashi Pharmaceutical Supplement for Menopause Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 113. Kobayashi Pharmaceutical Main Business
Table 114. Kobayashi Pharmaceutical Latest Developments
Table 115. Makers Nutrition Basic Information, Supplement for Menopause Manufacturing Base, Sales Area and Its Competitors
Table 116. Makers Nutrition Supplement for Menopause Product Portfolios and Specifications
Table 117. Makers Nutrition Supplement for Menopause Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 118. Makers Nutrition Main Business
Table 119. Makers Nutrition Latest Developments
Table 120. Menoelle Basic Information, Supplement for Menopause Manufacturing Base, Sales Area and Its Competitors
Table 121. Menoelle Supplement for Menopause Product Portfolios and Specifications
Table 122. Menoelle Supplement for Menopause Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 123. Menoelle Main Business
Table 124. Menoelle Latest Developments
Table 125. MenoLabs Basic Information, Supplement for Menopause Manufacturing Base, Sales Area and Its Competitors
Table 126. MenoLabs Supplement for Menopause Product Portfolios and Specifications
Table 127. MenoLabs Supplement for Menopause Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 128. MenoLabs Main Business
Table 129. MenoLabs Latest Developments
Table 130. Menopace Basic Information, Supplement for Menopause Manufacturing Base, Sales Area and Its Competitors
Table 131. Menopace Supplement for Menopause Product Portfolios and Specifications
Table 132. Menopace Supplement for Menopause Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 133. Menopace Main Business
Table 134. Menopace Latest Developments
Table 135. New Nordic Basic Information, Supplement for Menopause Manufacturing Base, Sales Area and Its Competitors
Table 136. New Nordic Supplement for Menopause Product Portfolios and Specifications
Table 137. New Nordic Supplement for Menopause Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 138. New Nordic Main Business
Table 139. New Nordic Latest Developments
Table 140. Nordic Naturals Basic Information, Supplement for Menopause Manufacturing Base, Sales Area and Its Competitors
Table 141. Nordic Naturals Supplement for Menopause Product Portfolios and Specifications
Table 142. Nordic Naturals Supplement for Menopause Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 143. Nordic Naturals Main Business
Table 144. Nordic Naturals Latest Developments
Table 145. Otsuka Pharmaceutical Basic Information, Supplement for Menopause Manufacturing Base, Sales Area and Its Competitors
Table 146. Otsuka Pharmaceutical Supplement for Menopause Product Portfolios and Specifications
Table 147. Otsuka Pharmaceutical Supplement for Menopause Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 148. Otsuka Pharmaceutical Main Business
Table 149. Otsuka Pharmaceutical Latest Developments
Table 150. PharmaLinea Basic Information, Supplement for Menopause Manufacturing Base, Sales Area and Its Competitors
Table 151. PharmaLinea Supplement for Menopause Product Portfolios and Specifications
Table 152. PharmaLinea Supplement for Menopause Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 153. PharmaLinea Main Business
Table 154. PharmaLinea Latest Developments
Table 155. PhytoLife Pharma Basic Information, Supplement for Menopause Manufacturing Base, Sales Area and Its Competitors
Table 156. PhytoLife Pharma Supplement for Menopause Product Portfolios and Specifications
Table 157. PhytoLife Pharma Supplement for Menopause Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 158. PhytoLife Pharma Main Business
Table 159. PhytoLife Pharma Latest Developments
Table 160. Promensil Basic Information, Supplement for Menopause Manufacturing Base, Sales Area and Its Competitors
Table 161. Promensil Supplement for Menopause Product Portfolios and Specifications
Table 162. Promensil Supplement for Menopause Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 163. Promensil Main Business
Table 164. Promensil Latest Developments
Table 165. SMPNutra Basic Information, Supplement for Menopause Manufacturing Base, Sales Area and Its Competitors
Table 166. SMPNutra Supplement for Menopause Product Portfolios and Specifications
Table 167. SMPNutra Supplement for Menopause Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 168. SMPNutra Main Business
Table 169. SMPNutra Latest Developments
Table 170. The Better Menopause Basic Information, Supplement for Menopause Manufacturing Base, Sales Area and Its Competitors
Table 171. The Better Menopause Supplement for Menopause Product Portfolios and Specifications
Table 172. The Better Menopause Supplement for Menopause Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 173. The Better Menopause Main Business
Table 174. The Better Menopause Latest Developments
Table 175. Vitabiotics Basic Information, Supplement for Menopause Manufacturing Base, Sales Area and Its Competitors
Table 176. Vitabiotics Supplement for Menopause Product Portfolios and Specifications
Table 177. Vitabiotics Supplement for Menopause Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 178. Vitabiotics Main Business
Table 179. Vitabiotics Latest Developments

List of Figures
Figure 1. Picture of Supplement for Menopause
Figure 2. Supplement for Menopause Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Supplement for Menopause Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Supplement for Menopause Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Supplement for Menopause Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Supplement for Menopause Sales Market Share by Country/Region (2025)
Figure 10. Supplement for Menopause Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Hormone Regulation Supplements
Figure 12. Product Picture of Bone Health Supplements
Figure 13. Product Picture of Cardiovascular and Metabolic Support Supplements
Figure 14. Product Picture of Mood and Sleep Regulation Supplements
Figure 15. Product Picture of Others
Figure 16. Global Supplement for Menopause Sales Market Share by Type in 2026
Figure 17. Global Supplement for Menopause Revenue Market Share by Type (2021-2026)
Figure 18. Supplement for Menopause Consumed in Online Pharmacies
Figure 19. Global Supplement for Menopause Market: Online Pharmacies (2021-2026) & (K Units)
Figure 20. Supplement for Menopause Consumed in Retail Pharmacies
Figure 21. Global Supplement for Menopause Market: Retail Pharmacies (2021-2026) & (K Units)
Figure 22. Supplement for Menopause Consumed in Hospital
Figure 23. Global Supplement for Menopause Market: Hospital (2021-2026) & (K Units)
Figure 24. Global Supplement for Menopause Sale Market Share by Application (2025)
Figure 25. Global Supplement for Menopause Revenue Market Share by Application in 2026
Figure 26. Supplement for Menopause Sales by Company in 2026 (K Units)
Figure 27. Global Supplement for Menopause Sales Market Share by Company in 2026
Figure 28. Supplement for Menopause Revenue by Company in 2026 ($ millions)
Figure 29. Global Supplement for Menopause Revenue Market Share by Company in 2026
Figure 30. Global Supplement for Menopause Sales Market Share by Geographic Region (2021-2026)
Figure 31. Global Supplement for Menopause Revenue Market Share by Geographic Region in 2026
Figure 32. Americas Supplement for Menopause Sales 2021-2026 (K Units)
Figure 33. Americas Supplement for Menopause Revenue 2021-2026 ($ millions)
Figure 34. APAC Supplement for Menopause Sales 2021-2026 (K Units)
Figure 35. APAC Supplement for Menopause Revenue 2021-2026 ($ millions)
Figure 36. Europe Supplement for Menopause Sales 2021-2026 (K Units)
Figure 37. Europe Supplement for Menopause Revenue 2021-2026 ($ millions)
Figure 38. Middle East & Africa Supplement for Menopause Sales 2021-2026 (K Units)
Figure 39. Middle East & Africa Supplement for Menopause Revenue 2021-2026 ($ millions)
Figure 40. Americas Supplement for Menopause Sales Market Share by Country in 2026
Figure 41. Americas Supplement for Menopause Revenue Market Share by Country (2021-2026)
Figure 42. Americas Supplement for Menopause Sales Market Share by Type (2021-2026)
Figure 43. Americas Supplement for Menopause Sales Market Share by Application (2021-2026)
Figure 44. United States Supplement for Menopause Revenue Growth 2021-2026 ($ millions)
Figure 45. Canada Supplement for Menopause Revenue Growth 2021-2026 ($ millions)
Figure 46. Mexico Supplement for Menopause Revenue Growth 2021-2026 ($ millions)
Figure 47. Brazil Supplement for Menopause Revenue Growth 2021-2026 ($ millions)
Figure 48. APAC Supplement for Menopause Sales Market Share by Region in 2026
Figure 49. APAC Supplement for Menopause Revenue Market Share by Region (2021-2026)
Figure 50. APAC Supplement for Menopause Sales Market Share by Type (2021-2026)
Figure 51. APAC Supplement for Menopause Sales Market Share by Application (2021-2026)
Figure 52. China Supplement for Menopause Revenue Growth 2021-2026 ($ millions)
Figure 53. Japan Supplement for Menopause Revenue Growth 2021-2026 ($ millions)
Figure 54. South Korea Supplement for Menopause Revenue Growth 2021-2026 ($ millions)
Figure 55. Southeast Asia Supplement for Menopause Revenue Growth 2021-2026 ($ millions)
Figure 56. India Supplement for Menopause Revenue Growth 2021-2026 ($ millions)
Figure 57. Australia Supplement for Menopause Revenue Growth 2021-2026 ($ millions)
Figure 58. China Taiwan Supplement for Menopause Revenue Growth 2021-2026 ($ millions)
Figure 59. Europe Supplement for Menopause Sales Market Share by Country in 2026
Figure 60. Europe Supplement for Menopause Revenue Market Share by Country (2021-2026)
Figure 61. Europe Supplement for Menopause Sales Market Share by Type (2021-2026)
Figure 62. Europe Supplement for Menopause Sales Market Share by Application (2021-2026)
Figure 63. Germany Supplement for Menopause Revenue Growth 2021-2026 ($ millions)
Figure 64. France Supplement for Menopause Revenue Growth 2021-2026 ($ millions)
Figure 65. UK Supplement for Menopause Revenue Growth 2021-2026 ($ millions)
Figure 66. Italy Supplement for Menopause Revenue Growth 2021-2026 ($ millions)
Figure 67. Russia Supplement for Menopause Revenue Growth 2021-2026 ($ millions)
Figure 68. Middle East & Africa Supplement for Menopause Sales Market Share by Country (2021-2026)
Figure 69. Middle East & Africa Supplement for Menopause Sales Market Share by Type (2021-2026)
Figure 70. Middle East & Africa Supplement for Menopause Sales Market Share by Application (2021-2026)
Figure 71. Egypt Supplement for Menopause Revenue Growth 2021-2026 ($ millions)
Figure 72. South Africa Supplement for Menopause Revenue Growth 2021-2026 ($ millions)
Figure 73. Israel Supplement for Menopause Revenue Growth 2021-2026 ($ millions)
Figure 74. Turkey Supplement for Menopause Revenue Growth 2021-2026 ($ millions)
Figure 75. GCC Countries Supplement for Menopause Revenue Growth 2021-2026 ($ millions)
Figure 76. Manufacturing Cost Structure Analysis of Supplement for Menopause in 2026
Figure 77. Manufacturing Process Analysis of Supplement for Menopause
Figure 78. Industry Chain Structure of Supplement for Menopause
Figure 79. Channels of Distribution
Figure 80. Global Supplement for Menopause Sales Market Forecast by Region (2027-2032)
Figure 81. Global Supplement for Menopause Revenue Market Share Forecast by Region (2027-2032)
Figure 82. Global Supplement for Menopause Sales Market Share Forecast by Type (2027-2032)
Figure 83. Global Supplement for Menopause Revenue Market Share Forecast by Type (2027-2032)
Figure 84. Global Supplement for Menopause Sales Market Share Forecast by Application (2027-2032)
Figure 85. Global Supplement for Menopause Revenue Market Share Forecast by Application (2027-2032)

 

ページTOPに戻る


 

Summary

The global Supplement for Menopause market size is predicted to grow from US$ 1794 million in 2025 to US$ 3296 million in 2032; it is expected to grow at a CAGR of 9.3% from 2026 to 2032.
Supplement for Menopause is a dietary supplement product designed to relieve the physical and psychological discomfort symptoms caused by ovarian dysfunction, fluctuations or decreases in estrogen levels in women during menopause. It usually uses natural plant extracts (such as soy isoflavones, black cohosh, and pomegranate flavonoids), vitamins (such as vitamin D and B vitamins), minerals (such as calcium, magnesium, and zinc), probiotics (such as specific strains that regulate the intestinal-estrogen axis), and Omega-3 fatty acids as core ingredients. Through scientific proportions, it simulates or supports hormone balance in the body, strengthens bone health, improves nerve conduction function, regulates mood and antioxidant defense system, and aims to help menopausal women smoothly pass through the physiological transition period of drastic hormone fluctuations and reduce osteoporosis, cardiovascular disease, cognitive decline, etc.
The global market for Supplement for Menopause is welcoming multiple development opportunities and significant trends. With the acceleration of global population aging, it is estimated that by 2030, more than 1.2 billion women will enter menopause worldwide, with more than 200 million menopausal women in China alone. The huge consumer group has laid a solid foundation for market growth. At the same time, women's health awareness has significantly improved, and more than 80% of menopausal women experience discomfort symptoms. The demand for relieving hot flashes, insomnia, osteoporosis and other problems has driven market expansion. From the trend point of view, innovation in natural ingredients has become the core direction. Ingredients such as phytoestrogens (such as soy isoflavones, pomegranate flavonoids), collagen peptides, and Omega-3 fatty acids are favored. Clinical trials have confirmed that they can improve bone density, skin elasticity and cardiovascular health. The integration of personalization and technology is accelerating. The AI-driven nutrition system integrates blood indicators, diet records and other data to provide daily nutrition recommendations; wearable devices monitor heart rate variability and sleep quality to assist in the management of menopausal symptoms. In addition, the market is segmented and differentiated in competition. Women in first-tier cities prefer high-end medical services and digital tools, while lower-tier cities rely on doctor recommendations and cost-effective products. Companies need to optimize channels and marketing strategies for different levels. Overall, the Supplement for Menopause market will continue to expand driven by demand, policy guidance and technological innovation.
LP Information, Inc. (LPI) ' newest research report, the “Supplement for Menopause Industry Forecast” looks at past sales and reviews total world Supplement for Menopause sales in 2025, providing a comprehensive analysis by region and market sector of projected Supplement for Menopause sales for 2026 through 2032. With Supplement for Menopause sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Supplement for Menopause industry.
This Insight Report provides a comprehensive analysis of the global Supplement for Menopause landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Supplement for Menopause portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Supplement for Menopause market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Supplement for Menopause and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Supplement for Menopause.
This report presents a comprehensive overview, market shares, and growth opportunities of Supplement for Menopause market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Hormone Regulation Supplements
Bone Health Supplements
Cardiovascular and Metabolic Support Supplements
Mood and Sleep Regulation Supplements
Others
Segmentation by Application:
Online Pharmacies
Retail Pharmacies
Hospital
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
AdvaCare Pharma
Amerifit Brands (Estroven)
Biofarma Group
Bonafide Health
Equelle
Flourish
GNC
Kobayashi Pharmaceutical
Makers Nutrition
Menoelle
MenoLabs
Menopace
New Nordic
Nordic Naturals
Otsuka Pharmaceutical
PharmaLinea
PhytoLife Pharma
Promensil
SMPNutra
The Better Menopause
Vitabiotics
Key Questions Addressed in this Report
What is the 10-year outlook for the global Supplement for Menopause market?
What factors are driving Supplement for Menopause market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Supplement for Menopause market opportunities vary by end market size?
How does Supplement for Menopause break out by Type, by Application?



ページTOPに戻る


Table of Contents

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Supplement for Menopause Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Supplement for Menopause by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Supplement for Menopause by Country/Region, 2021, 2025 & 2032
2.2 Supplement for Menopause Segment by Type
2.2.1 Hormone Regulation Supplements
2.2.2 Bone Health Supplements
2.2.3 Cardiovascular and Metabolic Support Supplements
2.2.4 Mood and Sleep Regulation Supplements
2.2.5 Others
2.2.6 Supplement for Menopause Sales by Type
2.2.6.1 Global Supplement for Menopause Sales Market Share by Type (2021-2026)
2.2.6.2 Global Supplement for Menopause Revenue and Market Share by Type (2021-2026)
2.2.6.3 Global Supplement for Menopause Sale Price by Type (2021-2026)
2.3 Supplement for Menopause Segment by Application
2.3.1 Online Pharmacies
2.3.2 Retail Pharmacies
2.3.3 Hospital
2.3.4 Supplement for Menopause Sales by Application
2.3.4.1 Global Supplement for Menopause Sale Market Share by Application (2021-2026)
2.3.4.2 Global Supplement for Menopause Revenue and Market Share by Application (2021-2026)
2.3.4.3 Global Supplement for Menopause Sale Price by Application (2021-2026)

3 Global by Company
3.1 Global Supplement for Menopause Breakdown Data by Company
3.1.1 Global Supplement for Menopause Annual Sales by Company (2021-2026)
3.1.2 Global Supplement for Menopause Sales Market Share by Company (2021-2026)
3.2 Global Supplement for Menopause Annual Revenue by Company (2021-2026)
3.2.1 Global Supplement for Menopause Revenue by Company (2021-2026)
3.2.2 Global Supplement for Menopause Revenue Market Share by Company (2021-2026)
3.3 Global Supplement for Menopause Sale Price by Company
3.4 Key Manufacturers Supplement for Menopause Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Supplement for Menopause Product Location Distribution
3.4.2 Players Supplement for Menopause Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy

4 World Historic Review for Supplement for Menopause by Geographic Region
4.1 World Historic Supplement for Menopause Market Size by Geographic Region (2021-2026)
4.1.1 Global Supplement for Menopause Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Supplement for Menopause Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Supplement for Menopause Market Size by Country/Region (2021-2026)
4.2.1 Global Supplement for Menopause Annual Sales by Country/Region (2021-2026)
4.2.2 Global Supplement for Menopause Annual Revenue by Country/Region (2021-2026)
4.3 Americas Supplement for Menopause Sales Growth
4.4 APAC Supplement for Menopause Sales Growth
4.5 Europe Supplement for Menopause Sales Growth
4.6 Middle East & Africa Supplement for Menopause Sales Growth

5 Americas
5.1 Americas Supplement for Menopause Sales by Country
5.1.1 Americas Supplement for Menopause Sales by Country (2021-2026)
5.1.2 Americas Supplement for Menopause Revenue by Country (2021-2026)
5.2 Americas Supplement for Menopause Sales by Type (2021-2026)
5.3 Americas Supplement for Menopause Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC
6.1 APAC Supplement for Menopause Sales by Region
6.1.1 APAC Supplement for Menopause Sales by Region (2021-2026)
6.1.2 APAC Supplement for Menopause Revenue by Region (2021-2026)
6.2 APAC Supplement for Menopause Sales by Type (2021-2026)
6.3 APAC Supplement for Menopause Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 Europe
7.1 Europe Supplement for Menopause by Country
7.1.1 Europe Supplement for Menopause Sales by Country (2021-2026)
7.1.2 Europe Supplement for Menopause Revenue by Country (2021-2026)
7.2 Europe Supplement for Menopause Sales by Type (2021-2026)
7.3 Europe Supplement for Menopause Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 Middle East & Africa
8.1 Middle East & Africa Supplement for Menopause by Country
8.1.1 Middle East & Africa Supplement for Menopause Sales by Country (2021-2026)
8.1.2 Middle East & Africa Supplement for Menopause Revenue by Country (2021-2026)
8.2 Middle East & Africa Supplement for Menopause Sales by Type (2021-2026)
8.3 Middle East & Africa Supplement for Menopause Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Supplement for Menopause
10.3 Manufacturing Process Analysis of Supplement for Menopause
10.4 Industry Chain Structure of Supplement for Menopause

11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Supplement for Menopause Distributors
11.3 Supplement for Menopause Customer

12 World Forecast Review for Supplement for Menopause by Geographic Region
12.1 Global Supplement for Menopause Market Size Forecast by Region
12.1.1 Global Supplement for Menopause Forecast by Region (2027-2032)
12.1.2 Global Supplement for Menopause Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Supplement for Menopause Forecast by Type (2027-2032)
12.7 Global Supplement for Menopause Forecast by Application (2027-2032)

13 Key Players Analysis
13.1 AdvaCare Pharma
13.1.1 AdvaCare Pharma Company Information
13.1.2 AdvaCare Pharma Supplement for Menopause Product Portfolios and Specifications
13.1.3 AdvaCare Pharma Supplement for Menopause Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 AdvaCare Pharma Main Business Overview
13.1.5 AdvaCare Pharma Latest Developments
13.2 Amerifit Brands (Estroven)
13.2.1 Amerifit Brands (Estroven) Company Information
13.2.2 Amerifit Brands (Estroven) Supplement for Menopause Product Portfolios and Specifications
13.2.3 Amerifit Brands (Estroven) Supplement for Menopause Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Amerifit Brands (Estroven) Main Business Overview
13.2.5 Amerifit Brands (Estroven) Latest Developments
13.3 Biofarma Group
13.3.1 Biofarma Group Company Information
13.3.2 Biofarma Group Supplement for Menopause Product Portfolios and Specifications
13.3.3 Biofarma Group Supplement for Menopause Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Biofarma Group Main Business Overview
13.3.5 Biofarma Group Latest Developments
13.4 Bonafide Health
13.4.1 Bonafide Health Company Information
13.4.2 Bonafide Health Supplement for Menopause Product Portfolios and Specifications
13.4.3 Bonafide Health Supplement for Menopause Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Bonafide Health Main Business Overview
13.4.5 Bonafide Health Latest Developments
13.5 Equelle
13.5.1 Equelle Company Information
13.5.2 Equelle Supplement for Menopause Product Portfolios and Specifications
13.5.3 Equelle Supplement for Menopause Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Equelle Main Business Overview
13.5.5 Equelle Latest Developments
13.6 Flourish
13.6.1 Flourish Company Information
13.6.2 Flourish Supplement for Menopause Product Portfolios and Specifications
13.6.3 Flourish Supplement for Menopause Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Flourish Main Business Overview
13.6.5 Flourish Latest Developments
13.7 GNC
13.7.1 GNC Company Information
13.7.2 GNC Supplement for Menopause Product Portfolios and Specifications
13.7.3 GNC Supplement for Menopause Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 GNC Main Business Overview
13.7.5 GNC Latest Developments
13.8 Kobayashi Pharmaceutical
13.8.1 Kobayashi Pharmaceutical Company Information
13.8.2 Kobayashi Pharmaceutical Supplement for Menopause Product Portfolios and Specifications
13.8.3 Kobayashi Pharmaceutical Supplement for Menopause Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Kobayashi Pharmaceutical Main Business Overview
13.8.5 Kobayashi Pharmaceutical Latest Developments
13.9 Makers Nutrition
13.9.1 Makers Nutrition Company Information
13.9.2 Makers Nutrition Supplement for Menopause Product Portfolios and Specifications
13.9.3 Makers Nutrition Supplement for Menopause Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Makers Nutrition Main Business Overview
13.9.5 Makers Nutrition Latest Developments
13.10 Menoelle
13.10.1 Menoelle Company Information
13.10.2 Menoelle Supplement for Menopause Product Portfolios and Specifications
13.10.3 Menoelle Supplement for Menopause Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Menoelle Main Business Overview
13.10.5 Menoelle Latest Developments
13.11 MenoLabs
13.11.1 MenoLabs Company Information
13.11.2 MenoLabs Supplement for Menopause Product Portfolios and Specifications
13.11.3 MenoLabs Supplement for Menopause Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 MenoLabs Main Business Overview
13.11.5 MenoLabs Latest Developments
13.12 Menopace
13.12.1 Menopace Company Information
13.12.2 Menopace Supplement for Menopause Product Portfolios and Specifications
13.12.3 Menopace Supplement for Menopause Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 Menopace Main Business Overview
13.12.5 Menopace Latest Developments
13.13 New Nordic
13.13.1 New Nordic Company Information
13.13.2 New Nordic Supplement for Menopause Product Portfolios and Specifications
13.13.3 New Nordic Supplement for Menopause Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 New Nordic Main Business Overview
13.13.5 New Nordic Latest Developments
13.14 Nordic Naturals
13.14.1 Nordic Naturals Company Information
13.14.2 Nordic Naturals Supplement for Menopause Product Portfolios and Specifications
13.14.3 Nordic Naturals Supplement for Menopause Sales, Revenue, Price and Gross Margin (2021-2026)
13.14.4 Nordic Naturals Main Business Overview
13.14.5 Nordic Naturals Latest Developments
13.15 Otsuka Pharmaceutical
13.15.1 Otsuka Pharmaceutical Company Information
13.15.2 Otsuka Pharmaceutical Supplement for Menopause Product Portfolios and Specifications
13.15.3 Otsuka Pharmaceutical Supplement for Menopause Sales, Revenue, Price and Gross Margin (2021-2026)
13.15.4 Otsuka Pharmaceutical Main Business Overview
13.15.5 Otsuka Pharmaceutical Latest Developments
13.16 PharmaLinea
13.16.1 PharmaLinea Company Information
13.16.2 PharmaLinea Supplement for Menopause Product Portfolios and Specifications
13.16.3 PharmaLinea Supplement for Menopause Sales, Revenue, Price and Gross Margin (2021-2026)
13.16.4 PharmaLinea Main Business Overview
13.16.5 PharmaLinea Latest Developments
13.17 PhytoLife Pharma
13.17.1 PhytoLife Pharma Company Information
13.17.2 PhytoLife Pharma Supplement for Menopause Product Portfolios and Specifications
13.17.3 PhytoLife Pharma Supplement for Menopause Sales, Revenue, Price and Gross Margin (2021-2026)
13.17.4 PhytoLife Pharma Main Business Overview
13.17.5 PhytoLife Pharma Latest Developments
13.18 Promensil
13.18.1 Promensil Company Information
13.18.2 Promensil Supplement for Menopause Product Portfolios and Specifications
13.18.3 Promensil Supplement for Menopause Sales, Revenue, Price and Gross Margin (2021-2026)
13.18.4 Promensil Main Business Overview
13.18.5 Promensil Latest Developments
13.19 SMPNutra
13.19.1 SMPNutra Company Information
13.19.2 SMPNutra Supplement for Menopause Product Portfolios and Specifications
13.19.3 SMPNutra Supplement for Menopause Sales, Revenue, Price and Gross Margin (2021-2026)
13.19.4 SMPNutra Main Business Overview
13.19.5 SMPNutra Latest Developments
13.20 The Better Menopause
13.20.1 The Better Menopause Company Information
13.20.2 The Better Menopause Supplement for Menopause Product Portfolios and Specifications
13.20.3 The Better Menopause Supplement for Menopause Sales, Revenue, Price and Gross Margin (2021-2026)
13.20.4 The Better Menopause Main Business Overview
13.20.5 The Better Menopause Latest Developments
13.21 Vitabiotics
13.21.1 Vitabiotics Company Information
13.21.2 Vitabiotics Supplement for Menopause Product Portfolios and Specifications
13.21.3 Vitabiotics Supplement for Menopause Sales, Revenue, Price and Gross Margin (2021-2026)
13.21.4 Vitabiotics Main Business Overview
13.21.5 Vitabiotics Latest Developments

14 Research Findings and Conclusion

ページTOPに戻る



List of Tables/Graphs

List of Tables
Table 1. Supplement for Menopause Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Supplement for Menopause Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Hormone Regulation Supplements
Table 4. Major Players of Bone Health Supplements
Table 5. Major Players of Cardiovascular and Metabolic Support Supplements
Table 6. Major Players of Mood and Sleep Regulation Supplements
Table 7. Major Players of Others
Table 8. Global Supplement for Menopause Sales by Type (2021-2026) & (K Units)
Table 9. Global Supplement for Menopause Sales Market Share by Type (2021-2026)
Table 10. Global Supplement for Menopause Revenue by Type (2021-2026) & ($ million)
Table 11. Global Supplement for Menopause Revenue Market Share by Type (2021-2026)
Table 12. Global Supplement for Menopause Sale Price by Type (2021-2026) & (US$/Unit)
Table 13. Global Supplement for Menopause Sale by Application (2021-2026) & (K Units)
Table 14. Global Supplement for Menopause Sale Market Share by Application (2021-2026)
Table 15. Global Supplement for Menopause Revenue by Application (2021-2026) & ($ million)
Table 16. Global Supplement for Menopause Revenue Market Share by Application (2021-2026)
Table 17. Global Supplement for Menopause Sale Price by Application (2021-2026) & (US$/Unit)
Table 18. Global Supplement for Menopause Sales by Company (2021-2026) & (K Units)
Table 19. Global Supplement for Menopause Sales Market Share by Company (2021-2026)
Table 20. Global Supplement for Menopause Revenue by Company (2021-2026) & ($ millions)
Table 21. Global Supplement for Menopause Revenue Market Share by Company (2021-2026)
Table 22. Global Supplement for Menopause Sale Price by Company (2021-2026) & (US$/Unit)
Table 23. Key Manufacturers Supplement for Menopause Producing Area Distribution and Sales Area
Table 24. Players Supplement for Menopause Products Offered
Table 25. Supplement for Menopause Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 26. New Products and Potential Entrants
Table 27. Market M&A Activity & Strategy
Table 28. Global Supplement for Menopause Sales by Geographic Region (2021-2026) & (K Units)
Table 29. Global Supplement for Menopause Sales Market Share Geographic Region (2021-2026)
Table 30. Global Supplement for Menopause Revenue by Geographic Region (2021-2026) & ($ millions)
Table 31. Global Supplement for Menopause Revenue Market Share by Geographic Region (2021-2026)
Table 32. Global Supplement for Menopause Sales by Country/Region (2021-2026) & (K Units)
Table 33. Global Supplement for Menopause Sales Market Share by Country/Region (2021-2026)
Table 34. Global Supplement for Menopause Revenue by Country/Region (2021-2026) & ($ millions)
Table 35. Global Supplement for Menopause Revenue Market Share by Country/Region (2021-2026)
Table 36. Americas Supplement for Menopause Sales by Country (2021-2026) & (K Units)
Table 37. Americas Supplement for Menopause Sales Market Share by Country (2021-2026)
Table 38. Americas Supplement for Menopause Revenue by Country (2021-2026) & ($ millions)
Table 39. Americas Supplement for Menopause Sales by Type (2021-2026) & (K Units)
Table 40. Americas Supplement for Menopause Sales by Application (2021-2026) & (K Units)
Table 41. APAC Supplement for Menopause Sales by Region (2021-2026) & (K Units)
Table 42. APAC Supplement for Menopause Sales Market Share by Region (2021-2026)
Table 43. APAC Supplement for Menopause Revenue by Region (2021-2026) & ($ millions)
Table 44. APAC Supplement for Menopause Sales by Type (2021-2026) & (K Units)
Table 45. APAC Supplement for Menopause Sales by Application (2021-2026) & (K Units)
Table 46. Europe Supplement for Menopause Sales by Country (2021-2026) & (K Units)
Table 47. Europe Supplement for Menopause Revenue by Country (2021-2026) & ($ millions)
Table 48. Europe Supplement for Menopause Sales by Type (2021-2026) & (K Units)
Table 49. Europe Supplement for Menopause Sales by Application (2021-2026) & (K Units)
Table 50. Middle East & Africa Supplement for Menopause Sales by Country (2021-2026) & (K Units)
Table 51. Middle East & Africa Supplement for Menopause Revenue Market Share by Country (2021-2026)
Table 52. Middle East & Africa Supplement for Menopause Sales by Type (2021-2026) & (K Units)
Table 53. Middle East & Africa Supplement for Menopause Sales by Application (2021-2026) & (K Units)
Table 54. Key Market Drivers & Growth Opportunities of Supplement for Menopause
Table 55. Key Market Challenges & Risks of Supplement for Menopause
Table 56. Key Industry Trends of Supplement for Menopause
Table 57. Supplement for Menopause Raw Material
Table 58. Key Suppliers of Raw Materials
Table 59. Supplement for Menopause Distributors List
Table 60. Supplement for Menopause Customer List
Table 61. Global Supplement for Menopause Sales Forecast by Region (2027-2032) & (K Units)
Table 62. Global Supplement for Menopause Revenue Forecast by Region (2027-2032) & ($ millions)
Table 63. Americas Supplement for Menopause Sales Forecast by Country (2027-2032) & (K Units)
Table 64. Americas Supplement for Menopause Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 65. APAC Supplement for Menopause Sales Forecast by Region (2027-2032) & (K Units)
Table 66. APAC Supplement for Menopause Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 67. Europe Supplement for Menopause Sales Forecast by Country (2027-2032) & (K Units)
Table 68. Europe Supplement for Menopause Revenue Forecast by Country (2027-2032) & ($ millions)
Table 69. Middle East & Africa Supplement for Menopause Sales Forecast by Country (2027-2032) & (K Units)
Table 70. Middle East & Africa Supplement for Menopause Revenue Forecast by Country (2027-2032) & ($ millions)
Table 71. Global Supplement for Menopause Sales Forecast by Type (2027-2032) & (K Units)
Table 72. Global Supplement for Menopause Revenue Forecast by Type (2027-2032) & ($ millions)
Table 73. Global Supplement for Menopause Sales Forecast by Application (2027-2032) & (K Units)
Table 74. Global Supplement for Menopause Revenue Forecast by Application (2027-2032) & ($ millions)
Table 75. AdvaCare Pharma Basic Information, Supplement for Menopause Manufacturing Base, Sales Area and Its Competitors
Table 76. AdvaCare Pharma Supplement for Menopause Product Portfolios and Specifications
Table 77. AdvaCare Pharma Supplement for Menopause Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 78. AdvaCare Pharma Main Business
Table 79. AdvaCare Pharma Latest Developments
Table 80. Amerifit Brands (Estroven) Basic Information, Supplement for Menopause Manufacturing Base, Sales Area and Its Competitors
Table 81. Amerifit Brands (Estroven) Supplement for Menopause Product Portfolios and Specifications
Table 82. Amerifit Brands (Estroven) Supplement for Menopause Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 83. Amerifit Brands (Estroven) Main Business
Table 84. Amerifit Brands (Estroven) Latest Developments
Table 85. Biofarma Group Basic Information, Supplement for Menopause Manufacturing Base, Sales Area and Its Competitors
Table 86. Biofarma Group Supplement for Menopause Product Portfolios and Specifications
Table 87. Biofarma Group Supplement for Menopause Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 88. Biofarma Group Main Business
Table 89. Biofarma Group Latest Developments
Table 90. Bonafide Health Basic Information, Supplement for Menopause Manufacturing Base, Sales Area and Its Competitors
Table 91. Bonafide Health Supplement for Menopause Product Portfolios and Specifications
Table 92. Bonafide Health Supplement for Menopause Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 93. Bonafide Health Main Business
Table 94. Bonafide Health Latest Developments
Table 95. Equelle Basic Information, Supplement for Menopause Manufacturing Base, Sales Area and Its Competitors
Table 96. Equelle Supplement for Menopause Product Portfolios and Specifications
Table 97. Equelle Supplement for Menopause Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 98. Equelle Main Business
Table 99. Equelle Latest Developments
Table 100. Flourish Basic Information, Supplement for Menopause Manufacturing Base, Sales Area and Its Competitors
Table 101. Flourish Supplement for Menopause Product Portfolios and Specifications
Table 102. Flourish Supplement for Menopause Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 103. Flourish Main Business
Table 104. Flourish Latest Developments
Table 105. GNC Basic Information, Supplement for Menopause Manufacturing Base, Sales Area and Its Competitors
Table 106. GNC Supplement for Menopause Product Portfolios and Specifications
Table 107. GNC Supplement for Menopause Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 108. GNC Main Business
Table 109. GNC Latest Developments
Table 110. Kobayashi Pharmaceutical Basic Information, Supplement for Menopause Manufacturing Base, Sales Area and Its Competitors
Table 111. Kobayashi Pharmaceutical Supplement for Menopause Product Portfolios and Specifications
Table 112. Kobayashi Pharmaceutical Supplement for Menopause Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 113. Kobayashi Pharmaceutical Main Business
Table 114. Kobayashi Pharmaceutical Latest Developments
Table 115. Makers Nutrition Basic Information, Supplement for Menopause Manufacturing Base, Sales Area and Its Competitors
Table 116. Makers Nutrition Supplement for Menopause Product Portfolios and Specifications
Table 117. Makers Nutrition Supplement for Menopause Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 118. Makers Nutrition Main Business
Table 119. Makers Nutrition Latest Developments
Table 120. Menoelle Basic Information, Supplement for Menopause Manufacturing Base, Sales Area and Its Competitors
Table 121. Menoelle Supplement for Menopause Product Portfolios and Specifications
Table 122. Menoelle Supplement for Menopause Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 123. Menoelle Main Business
Table 124. Menoelle Latest Developments
Table 125. MenoLabs Basic Information, Supplement for Menopause Manufacturing Base, Sales Area and Its Competitors
Table 126. MenoLabs Supplement for Menopause Product Portfolios and Specifications
Table 127. MenoLabs Supplement for Menopause Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 128. MenoLabs Main Business
Table 129. MenoLabs Latest Developments
Table 130. Menopace Basic Information, Supplement for Menopause Manufacturing Base, Sales Area and Its Competitors
Table 131. Menopace Supplement for Menopause Product Portfolios and Specifications
Table 132. Menopace Supplement for Menopause Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 133. Menopace Main Business
Table 134. Menopace Latest Developments
Table 135. New Nordic Basic Information, Supplement for Menopause Manufacturing Base, Sales Area and Its Competitors
Table 136. New Nordic Supplement for Menopause Product Portfolios and Specifications
Table 137. New Nordic Supplement for Menopause Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 138. New Nordic Main Business
Table 139. New Nordic Latest Developments
Table 140. Nordic Naturals Basic Information, Supplement for Menopause Manufacturing Base, Sales Area and Its Competitors
Table 141. Nordic Naturals Supplement for Menopause Product Portfolios and Specifications
Table 142. Nordic Naturals Supplement for Menopause Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 143. Nordic Naturals Main Business
Table 144. Nordic Naturals Latest Developments
Table 145. Otsuka Pharmaceutical Basic Information, Supplement for Menopause Manufacturing Base, Sales Area and Its Competitors
Table 146. Otsuka Pharmaceutical Supplement for Menopause Product Portfolios and Specifications
Table 147. Otsuka Pharmaceutical Supplement for Menopause Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 148. Otsuka Pharmaceutical Main Business
Table 149. Otsuka Pharmaceutical Latest Developments
Table 150. PharmaLinea Basic Information, Supplement for Menopause Manufacturing Base, Sales Area and Its Competitors
Table 151. PharmaLinea Supplement for Menopause Product Portfolios and Specifications
Table 152. PharmaLinea Supplement for Menopause Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 153. PharmaLinea Main Business
Table 154. PharmaLinea Latest Developments
Table 155. PhytoLife Pharma Basic Information, Supplement for Menopause Manufacturing Base, Sales Area and Its Competitors
Table 156. PhytoLife Pharma Supplement for Menopause Product Portfolios and Specifications
Table 157. PhytoLife Pharma Supplement for Menopause Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 158. PhytoLife Pharma Main Business
Table 159. PhytoLife Pharma Latest Developments
Table 160. Promensil Basic Information, Supplement for Menopause Manufacturing Base, Sales Area and Its Competitors
Table 161. Promensil Supplement for Menopause Product Portfolios and Specifications
Table 162. Promensil Supplement for Menopause Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 163. Promensil Main Business
Table 164. Promensil Latest Developments
Table 165. SMPNutra Basic Information, Supplement for Menopause Manufacturing Base, Sales Area and Its Competitors
Table 166. SMPNutra Supplement for Menopause Product Portfolios and Specifications
Table 167. SMPNutra Supplement for Menopause Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 168. SMPNutra Main Business
Table 169. SMPNutra Latest Developments
Table 170. The Better Menopause Basic Information, Supplement for Menopause Manufacturing Base, Sales Area and Its Competitors
Table 171. The Better Menopause Supplement for Menopause Product Portfolios and Specifications
Table 172. The Better Menopause Supplement for Menopause Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 173. The Better Menopause Main Business
Table 174. The Better Menopause Latest Developments
Table 175. Vitabiotics Basic Information, Supplement for Menopause Manufacturing Base, Sales Area and Its Competitors
Table 176. Vitabiotics Supplement for Menopause Product Portfolios and Specifications
Table 177. Vitabiotics Supplement for Menopause Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 178. Vitabiotics Main Business
Table 179. Vitabiotics Latest Developments

List of Figures
Figure 1. Picture of Supplement for Menopause
Figure 2. Supplement for Menopause Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Supplement for Menopause Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Supplement for Menopause Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Supplement for Menopause Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Supplement for Menopause Sales Market Share by Country/Region (2025)
Figure 10. Supplement for Menopause Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Hormone Regulation Supplements
Figure 12. Product Picture of Bone Health Supplements
Figure 13. Product Picture of Cardiovascular and Metabolic Support Supplements
Figure 14. Product Picture of Mood and Sleep Regulation Supplements
Figure 15. Product Picture of Others
Figure 16. Global Supplement for Menopause Sales Market Share by Type in 2026
Figure 17. Global Supplement for Menopause Revenue Market Share by Type (2021-2026)
Figure 18. Supplement for Menopause Consumed in Online Pharmacies
Figure 19. Global Supplement for Menopause Market: Online Pharmacies (2021-2026) & (K Units)
Figure 20. Supplement for Menopause Consumed in Retail Pharmacies
Figure 21. Global Supplement for Menopause Market: Retail Pharmacies (2021-2026) & (K Units)
Figure 22. Supplement for Menopause Consumed in Hospital
Figure 23. Global Supplement for Menopause Market: Hospital (2021-2026) & (K Units)
Figure 24. Global Supplement for Menopause Sale Market Share by Application (2025)
Figure 25. Global Supplement for Menopause Revenue Market Share by Application in 2026
Figure 26. Supplement for Menopause Sales by Company in 2026 (K Units)
Figure 27. Global Supplement for Menopause Sales Market Share by Company in 2026
Figure 28. Supplement for Menopause Revenue by Company in 2026 ($ millions)
Figure 29. Global Supplement for Menopause Revenue Market Share by Company in 2026
Figure 30. Global Supplement for Menopause Sales Market Share by Geographic Region (2021-2026)
Figure 31. Global Supplement for Menopause Revenue Market Share by Geographic Region in 2026
Figure 32. Americas Supplement for Menopause Sales 2021-2026 (K Units)
Figure 33. Americas Supplement for Menopause Revenue 2021-2026 ($ millions)
Figure 34. APAC Supplement for Menopause Sales 2021-2026 (K Units)
Figure 35. APAC Supplement for Menopause Revenue 2021-2026 ($ millions)
Figure 36. Europe Supplement for Menopause Sales 2021-2026 (K Units)
Figure 37. Europe Supplement for Menopause Revenue 2021-2026 ($ millions)
Figure 38. Middle East & Africa Supplement for Menopause Sales 2021-2026 (K Units)
Figure 39. Middle East & Africa Supplement for Menopause Revenue 2021-2026 ($ millions)
Figure 40. Americas Supplement for Menopause Sales Market Share by Country in 2026
Figure 41. Americas Supplement for Menopause Revenue Market Share by Country (2021-2026)
Figure 42. Americas Supplement for Menopause Sales Market Share by Type (2021-2026)
Figure 43. Americas Supplement for Menopause Sales Market Share by Application (2021-2026)
Figure 44. United States Supplement for Menopause Revenue Growth 2021-2026 ($ millions)
Figure 45. Canada Supplement for Menopause Revenue Growth 2021-2026 ($ millions)
Figure 46. Mexico Supplement for Menopause Revenue Growth 2021-2026 ($ millions)
Figure 47. Brazil Supplement for Menopause Revenue Growth 2021-2026 ($ millions)
Figure 48. APAC Supplement for Menopause Sales Market Share by Region in 2026
Figure 49. APAC Supplement for Menopause Revenue Market Share by Region (2021-2026)
Figure 50. APAC Supplement for Menopause Sales Market Share by Type (2021-2026)
Figure 51. APAC Supplement for Menopause Sales Market Share by Application (2021-2026)
Figure 52. China Supplement for Menopause Revenue Growth 2021-2026 ($ millions)
Figure 53. Japan Supplement for Menopause Revenue Growth 2021-2026 ($ millions)
Figure 54. South Korea Supplement for Menopause Revenue Growth 2021-2026 ($ millions)
Figure 55. Southeast Asia Supplement for Menopause Revenue Growth 2021-2026 ($ millions)
Figure 56. India Supplement for Menopause Revenue Growth 2021-2026 ($ millions)
Figure 57. Australia Supplement for Menopause Revenue Growth 2021-2026 ($ millions)
Figure 58. China Taiwan Supplement for Menopause Revenue Growth 2021-2026 ($ millions)
Figure 59. Europe Supplement for Menopause Sales Market Share by Country in 2026
Figure 60. Europe Supplement for Menopause Revenue Market Share by Country (2021-2026)
Figure 61. Europe Supplement for Menopause Sales Market Share by Type (2021-2026)
Figure 62. Europe Supplement for Menopause Sales Market Share by Application (2021-2026)
Figure 63. Germany Supplement for Menopause Revenue Growth 2021-2026 ($ millions)
Figure 64. France Supplement for Menopause Revenue Growth 2021-2026 ($ millions)
Figure 65. UK Supplement for Menopause Revenue Growth 2021-2026 ($ millions)
Figure 66. Italy Supplement for Menopause Revenue Growth 2021-2026 ($ millions)
Figure 67. Russia Supplement for Menopause Revenue Growth 2021-2026 ($ millions)
Figure 68. Middle East & Africa Supplement for Menopause Sales Market Share by Country (2021-2026)
Figure 69. Middle East & Africa Supplement for Menopause Sales Market Share by Type (2021-2026)
Figure 70. Middle East & Africa Supplement for Menopause Sales Market Share by Application (2021-2026)
Figure 71. Egypt Supplement for Menopause Revenue Growth 2021-2026 ($ millions)
Figure 72. South Africa Supplement for Menopause Revenue Growth 2021-2026 ($ millions)
Figure 73. Israel Supplement for Menopause Revenue Growth 2021-2026 ($ millions)
Figure 74. Turkey Supplement for Menopause Revenue Growth 2021-2026 ($ millions)
Figure 75. GCC Countries Supplement for Menopause Revenue Growth 2021-2026 ($ millions)
Figure 76. Manufacturing Cost Structure Analysis of Supplement for Menopause in 2026
Figure 77. Manufacturing Process Analysis of Supplement for Menopause
Figure 78. Industry Chain Structure of Supplement for Menopause
Figure 79. Channels of Distribution
Figure 80. Global Supplement for Menopause Sales Market Forecast by Region (2027-2032)
Figure 81. Global Supplement for Menopause Revenue Market Share Forecast by Region (2027-2032)
Figure 82. Global Supplement for Menopause Sales Market Share Forecast by Type (2027-2032)
Figure 83. Global Supplement for Menopause Revenue Market Share Forecast by Type (2027-2032)
Figure 84. Global Supplement for Menopause Sales Market Share Forecast by Application (2027-2032)
Figure 85. Global Supplement for Menopause Revenue Market Share Forecast by Application (2027-2032)

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります


よくあるご質問


LP Information社はどのような調査会社ですか?


LP Informationは通信、エネルギー、医薬をはじめとする広範な市場の調査とレポート出版を行っている調査会社です。 もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。


詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

 

2026/11/09 10:26

159.34 円

177.97 円

215.56 円

ページTOPに戻る